Williams J P, Bourke D L
Anesthesiology. 1985 Sep;63(3):299-303. doi: 10.1097/00000542-198509000-00010.
Succinylcholine was administered to 10 healthy unanesthetized volunteers to assess its effect on respiratory and nonrespiratory muscle strength and the ventilatory response to CO2. Iso hypercapnia with PETCO2 8-10 mmHg above control was maintained throughout the study, succinylcholine infusion rates were increased from 20 micrograms X kg-1 X min-1 until grip strength (GS) was 20% of control. CO2-stimulated ventilation was 16.1 +/- 1.8 l/min (mean +/- SD), approximately three times control, and remained at that level throughout the study because of nonsignificant decreases in tidal volume and increases in respiratory frequency. Respiratory strength, as measured by maximum inspiratory pressure (IP), maximum expiratory pressure (EP), and forced vital capacity (FVC), was spared relative to GS. When GS = 50% of control, IP = 86 +/- 8% of control, EP = 78 +/- 15%, and FVC = 86 +/- 9%. Wide variation occurred from subject to subject in the succinylcholine versus GS dose-response curve position. However, in all subjects the slope of the dose-response curve was very steep.
将琥珀酰胆碱给予10名健康未麻醉的志愿者,以评估其对呼吸和非呼吸肌力量以及对二氧化碳通气反应的影响。在整个研究过程中,维持呼气末二氧化碳分压(PETCO2)比对照高8 - 10 mmHg的等容高碳酸血症,琥珀酰胆碱输注速率从20微克×千克-1×分钟-1增加,直至握力(GS)为对照的20%。二氧化碳刺激的通气量为16.1±1.8升/分钟(平均值±标准差),约为对照的三倍,并且由于潮气量无显著下降和呼吸频率增加,在整个研究过程中保持在该水平。相对于握力,通过最大吸气压力(IP)、最大呼气压力(EP)和用力肺活量(FVC)测量的呼吸力量得以保留。当握力为对照的50%时,最大吸气压力为对照的86±8%,最大呼气压力为78±15%,用力肺活量为86±9%。琥珀酰胆碱与握力的剂量反应曲线位置在受试者之间存在很大差异。然而,在所有受试者中,剂量反应曲线的斜率都非常陡峭。